These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 1847583)

  • 21. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta.
    Ellis A; Li CG; Rand MJ
    Br J Pharmacol; 2000 Jan; 129(2):315-22. PubMed ID: 10694238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effect of 17 beta-estradiol on vasomotor responses of aorta from cholesterol-fed rabbit is reduced by inhibitors of superoxide dismutase and catalase.
    Ghanam K; Javellaud J; Ea-Kim L; Oudart N
    Biochem Biophys Res Commun; 1998 Aug; 249(3):858-64. PubMed ID: 9731227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is nitric oxide the only endothelium-derived relaxing factor in canine femoral veins?
    Miller VM; Vanhoutte PM
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1910-6. PubMed ID: 2513730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
    White DG; Martin W
    Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a high salt diet on microvascular antioxidant enzymes.
    Lenda DM; Boegehold MA
    J Vasc Res; 2002; 39(1):41-50. PubMed ID: 11844936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of endothelium-derived relaxing factor from pig cultured aortic endothelial cells, as assessed by changes in endothelial cell cyclic GMP content, is inhibited by a phorbol ester.
    Smith JA; Lang D
    Br J Pharmacol; 1990 Mar; 99(3):565-71. PubMed ID: 1691949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
    Korenaga R
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide.
    Katusic ZS; Marshall JJ; Kontos HA; Vanhoutte PM
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1235-9. PubMed ID: 2552840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
    Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary endothelium is responsive to bradykinin and arachidonate but not to acetylcholine.
    Harasawa Y; Kimura M; Ohno Y; Hayashi S
    Arch Int Pharmacodyn Ther; 1989; 302():196-208. PubMed ID: 2517685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular smooth muscle influences the release of endothelium-derived relaxing factor.
    Warren JB; Brady AJ; Taylor GW
    Proc Biol Sci; 1990 Aug; 241(1301):127-31. PubMed ID: 1978339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle.
    Rubanyi GM; Vanhoutte PM
    Am J Physiol; 1986 May; 250(5 Pt 2):H815-21. PubMed ID: 3085520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses.
    Mombouli JV; Nephtali M; Vanhoutte PM
    Hypertension; 1991 Oct; 18(4 Suppl):II22-9. PubMed ID: 1916998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of magnesium on basal and agonist-induced EDRF relaxation in canine coronary arteries.
    Ku DD; Ann HS
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):999-1006. PubMed ID: 1714027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oxygen tension on endothelium dependent responses in canine coronary microvessels.
    Myers PR; Muller JM; Tanner MA
    Cardiovasc Res; 1991 Nov; 25(11):885-94. PubMed ID: 1813116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of calcium relaxation of vascular smooth muscle.
    Wu CC; Bohr DF
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1411-6. PubMed ID: 1951728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig.
    Shimokawa H; Flavahan NA; Lorenz RR; Vanhoutte PM
    Br J Pharmacol; 1988 Dec; 95(4):1197-203. PubMed ID: 3064855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-reoxygenation impairs endothelium-dependent relaxation in isolated rat aorta.
    Yokoyama S; Korthuis RJ; Benoit JN
    Am J Physiol; 1996 May; 270(5 Pt 2):R1126-31. PubMed ID: 8928916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.